These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31231915)

  • 1. Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer.
    Udupa S; Nguyen S; Hoang G; Nguyen T; Quinones A; Pham K; Asaka R; Nguyen K; Zhang C; Elgogary A; Jung JG; Xu Q; Fu J; Thomas AG; Tsukamoto T; Hanes J; Slusher BS; Cooper AJL; Le A
    Proteomics; 2019 Nov; 19(21-22):e1800451. PubMed ID: 31231915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic importance of the glutaminase II pathway in normal and cancerous cells.
    Dorai T; Pinto JT; Denton TT; Krasnikov BF; Cooper AJL
    Anal Biochem; 2022 May; 644():114083. PubMed ID: 33352190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.
    Matre P; Velez J; Jacamo R; Qi Y; Su X; Cai T; Chan SM; Lodi A; Sweeney SR; Ma H; Davis RE; Baran N; Haferlach T; Su X; Flores ER; Gonzalez D; Konoplev S; Samudio I; DiNardo C; Majeti R; Schimmer AD; Li W; Wang T; Tiziani S; Konopleva M
    Oncotarget; 2016 Nov; 7(48):79722-79735. PubMed ID: 27806325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition.
    Hamada S; Matsumoto R; Tanaka Y; Taguchi K; Yamamoto M; Masamune A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Levels of Glutaminase II Pathway Enzymes in Normal and Cancerous Prostate Suggest a Role in 'Glutamine Addiction'.
    Dorai T; Dorai B; Pinto JT; Grasso M; Cooper AJL
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31861280
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting cellular metabolism to reduce head and neck cancer growth.
    Yang J; Guo Y; Seo W; Zhang R; Lu C; Wang Y; Luo L; Paul B; Yan W; Saxena D; Li X
    Sci Rep; 2019 Mar; 9(1):4995. PubMed ID: 30899051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous inhibition of PFKFB3 and GLS1 selectively kills KRAS-transformed pancreatic cells.
    Ozcan SC; Mutlu A; Altunok TH; Gurpinar Y; Sarioglu A; Guler S; Muchut RJ; Iglesias AA; Celikler S; Campbell PM; Yalcin A
    Biochem Biophys Res Commun; 2021 Sep; 571():118-124. PubMed ID: 34325126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism.
    Biancur DE; Paulo JA; Małachowska B; Quiles Del Rey M; Sousa CM; Wang X; Sohn ASW; Chu GC; Gygi SP; Harper JW; Fendler W; Mancias JD; Kimmelman AC
    Nat Commun; 2017 Jul; 8():15965. PubMed ID: 28671190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer.
    Pan T; Gao L; Wu G; Shen G; Xie S; Wen H; Yang J; Zhou Y; Tu Z; Qian W
    Biochem Biophys Res Commun; 2015 Jan; 456(1):452-8. PubMed ID: 25482439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glutaminase 1-mediated glutaminolysis improves pathological cardiac remodeling.
    Yoshikawa S; Nagao M; Toh R; Shinohara M; Iino T; Irino Y; Nishimori M; Tanaka H; Satomi-Kobayashi S; Ishida T; Hirata KI
    Am J Physiol Heart Circ Physiol; 2022 May; 322(5):H749-H761. PubMed ID: 35275762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells.
    Peyton KJ; Liu XM; Yu Y; Yates B; Behnammanesh G; Durante W
    Biochem Pharmacol; 2018 Oct; 156():204-214. PubMed ID: 30144404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
    Jacque N; Ronchetti AM; Larrue C; Meunier G; Birsen R; Willems L; Saland E; Decroocq J; Maciel TT; Lambert M; Poulain L; Hospital MA; Sujobert P; Joseph L; Chapuis N; Lacombe C; Moura IC; Demo S; Sarry JE; Recher C; Mayeux P; Tamburini J; Bouscary D
    Blood; 2015 Sep; 126(11):1346-56. PubMed ID: 26186940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy.
    Masamha CP; LaFontaine P
    J Cell Biochem; 2018 Jul; 119(7):6136-6145. PubMed ID: 29633308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain slices from glutaminase-deficient mice metabolize less glutamine: a cellular metabolomic study with carbon 13 NMR.
    El Hage M; Masson J; Conjard-Duplany A; Ferrier B; Baverel G; Martin G
    J Cereb Blood Flow Metab; 2012 May; 32(5):816-24. PubMed ID: 22373647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.
    Qie S; Chu C; Li W; Wang C; Sang N
    J Cell Biochem; 2014 Mar; 115(3):498-509. PubMed ID: 24122876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
    Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
    Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
    Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D
    EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease.
    Soomro I; Sun Y; Li Z; Diggs L; Hatzivassiliou G; Thomas AG; Rais R; Parker SJ; Slusher BS; Kimmelman AC; Somlo S; Skolnik EY
    Nephrol Dial Transplant; 2018 Aug; 33(8):1343-1353. PubMed ID: 29420817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.
    Chen L; Cui H
    Int J Mol Sci; 2015 Sep; 16(9):22830-55. PubMed ID: 26402672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.
    Gregory MA; Nemkov T; Reisz JA; Zaberezhnyy V; Hansen KC; D'Alessandro A; DeGregori J
    Exp Hematol; 2018 Feb; 58():52-58. PubMed ID: 28947392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.